Our results demonstrated that patients with positive ATF4 expression/lymph node metastasis (+) had poorer overall survival rates compared with those of the other patients (P<0.001; Fig. 2G). The gene discussed is ATF4; the disease is metastatic malignant neoplasm in the lymph nodes.